Summary
This biopharmaceutical company leverages machine learning to enhance the drug discovery process, specifically focusing on the Design-Make-Test cycle in medicinal chemistry. Their goal is to expedite the development of new cures for patients by utilizing advanced technology and forming strategic partnerships with other organizations in the industry.
Based on content on postera.ai
sygnaturediscovery.com
Nottingham, UK
Pharmaceutical Contract Research Organization (CRO)
We offer API access to our data.
8 of 8 checks passed
Label
Value
Active Dates
4.8 years — Since Mar 2020
Web Hosting
Platform
E-Mail Provider
Google GSuite
NAICS Code
325414
SIC 4 Digit Code
2834
SIC 2 Digit Code
28
Industry
1. Biopharmaceuticals and Drug Discovery
2. Biological Product (except Diagnostic) Manufacturing
Vendor
Source
Microsoft
TXT Record
TXT Record
Notion
TXT Record
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2020 |
|
|
|
|
|
|
|
|
|
|
|
|
| 2021 |
|
|
|
|
|
|
|
|
|
|
|
|
| 2022 |
|
|
|
|
|
|
|
|
|
|
|
|
| 2023 |
|
|
|
|
|
|
|
|
|
|
|
|
| 2024 |
|
|
|
|
|
|
|
|
|
|
|
|